The vision for genomics in biopharma ??
Hi there ??
Welcome to the April issue of our newsletter.
This month, Automata 's Lara Matthews met with Illumina 's Will Ferguson to discuss large-scale genomic data projects, drug discovery impact, and the future potential of whole genome sequencing in the clinic.
We're also giving you access to our latest whitepaper, which delves into lab automation solutions for CROs and CDMOs. Keep reading to download your free copy ??
We hope you enjoy!
Team Automata ??
Automata and Illumina in conversation, again
Lara Matthews , Strategic Account Director at Automata, spoke with Will Ferguson , VP of Pharmaceutical & Biotech Collaborations at Illumina , for an insightful discussion on the future of drug discovery in genomics.
They explore the potential impact of large-scale genetic data analysis on finding new therapeutic targets, anticipating breakthroughs in neuroscience and cardiometabolic diseases.
Watch the full interview below to learn how these advancements will shape the future of healthcare ??
Or, you can listen to the highlights by selecting a topic from the list below:
Delivering flexibility for CROs
Introducing our latest whitepaper, 'Infrastructure-level lab automation for changing client demands'.
This free whitepaper explores lab automation solutions available to CROs and CDMOs, the benefits they can bring, and how true infrastructure-level automation can revolutionise the lab experience for everyone – from scientists to clients to patients.
?? DOWNLOAD NOW
Design your lab
Have you built your dream lab with our Lab Configurator yet?
领英推荐
If you answered 'no', what are you waiting for?!
Configure the layout of your LINQ Bench and see what your own instruments would look like in a fully integrated, automated workflow set-up. Then, explore your design from every angle in rendered 3D and place it in your own lab space using AR technology.
?? BUILD IT NOW
TechBio x Drug Discovery
TechBio startups are making drug development faster, cheaper and more effective.?
According to an exclusive new report by Speedinvest and Dealroom.co , European TechBio companies raised $1.2 billion in VC funding in 2023. The report maps 450+ startups working to change drug discovery at every phase - from research to clinical trials and market access - with Automata being one of them!
Read the report now to discover the key drivers of the industry and which TechBio startups we're listed alongside.
Our upcoming events...
Want to speak to Team Automata about automating your lab? Catch us at one of the - many - events we're attending this May.
Follow the links below to book a 1:1 with us!
Not going to any of those events? You can still discuss the future of your lab with our team by booking a meeting. Just click the link below ??
??? BOOK A CHAT
Let's stay in touch
By subscribing to our newsletter, you'll get a copy of each newsletter delivered straight to your email inbox without having to lift a finger. Automation at its finest...
?? SUBSCRIBE HERE ??